This post was originally published on this site
Kwarteng is understood to be working with officials to better understand the plans Philip Morris has for Vectura, according to the report, which did not elaborate on the officials.
Philip Morris agreed on Friday to buy Vectura for 1.05 billion pounds ($1.45 billion), giving the U.S. firm access to the British drugmaker’s respiratory ailment treatments and inhaling device technology.
($1 = 0.7244 pounds)
